Association between clinical characteristics and the diagnostic accuracy of circulating single-molecule amplification and resequencing technology on detection epidermal growth factor receptor mutation status in plasma of lung adenocarcinoma.

Abstract excerpt

BACKGROUND: Lung cancer is the leading cause of cancer-related mortality in the world. Circulating single-molecule amplification and resequencing technology (cSMART) can successfully detect epidermal growth factor receptor (EGFR) mutation in non-small cell lung cancer (NSCLC). However, few studies have investigated the association between clinical characteristics and the diagnostic accuracy of cSMART technique in...

Topics

Join the communities discussing this publication.

• Adenocarcinoma
• Adenocarcinoma of Lung
• Aged, 80 and over
• DNA Mutational Analysis
• ErbB Receptors